The Appointments Committee of the Cabinet has approved the nomination of Shri Arun Jha as Additional Secretary, Department of Administrative Reforms and Public Grievances, Ministry of Personnel, Public Grievances and Pensions in the vacancy of Shri Shashi Shekhar (IAS-TN-81). Shri Jha, an IAS officer of 1981 batch (Bihar Cadre), is presently Chief Vigilance Officer, BHEL, Department of Heavy Industry, Ministry of Heavy Industries and Public Enterprises.
Jha is a Gold medalist and holds a MA in Political Science from Delhi University. His main areas of academic training at the Master’s level include the political economy of Japan and China as well as study of the political and economic institutions of Africa. During 1995-96 he was a World Bank Scholar in the Department of Urban Studies and Planning at MIT, USA. He has held a variety of assignments in Government, both with the State Government of Bihar and at the central government level. At the State Government level, he headed the Directorate of small Savings, Social Security, Employment and Training while being the Sugarcane Commissioner looking after Sugar Industry.
At the Government of India level, Mr. Jha, was Director in the Ministry of Agriculture looking after National Disaster Management. Subsequently, he joined the Home Ministry assisting the Minister of State of Home Affairs in the field of North East Development, Human Rights, etc. Mr. Jha, was also the Secretary in the State Government of Bihar in the Department of Food and Civil supplies, Excise and Prohibition, Official Languages while also assisting the Additional Finance Commissioner (Resources) and Managing Director of Bihar State Cooperative Bank before being posted in Government of India in August 2006 as Member Secretary of National Pharmaceutical Pricing Authority in the Ministry of Chemicals & Fertilizers. Before being posted to the Dept of Admin Reforms, he held the position of Joint Secretary, Department of Pharmaceuticals in the Government of India. He is said to possess a keen interest in the social and developmental issues particularly issues relating to affordability of drugs and health care for the poor, Drug R&D, Pharma Education, Social Protection, Development Economics issues relating to Industry and Commerce.